FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616971700> ?p ?o ?g. }

• W2616971700 abstract "Background Survivors of stroke due to intracerebral haemorrhage (ICH) are at risk of thromboembolism. Antithrombotic (antiplatelet or anticoagulant) treatments may lower the risk of thromboembolism after ICH, but they may increase the risks of bleeding. Objectives To determine the overall effectiveness and safety of antithrombotic drugs for people with ICH. Search methods We searched the Cochrane Stroke Group Trials Register (24 March 2017). We also searched the Cochrane Central Register of Controlled Trials (CENTRAL: the Cochrane Library 2017, Issue 3), MEDLINE Ovid (from 1948 to March 2017), Embase Ovid (from 1980 to March 2017), and online registries of clinical trials (8 March 2017). We also screened the reference lists of included trials for additional, potentially relevant studies. Selection criteria We selected all randomised controlled trials (RCTs) of any antithrombotic treatment after ICH. Data collection and analysis Three review authors independently extracted data. We converted categorical estimates of effect to the risk ratio (RR) or odds ratio (OR), as appropriate. We divided our analyses into short‐ and long‐term treatment, and used fixed‐effect modelling for meta‐analyses. Three review authors independently assessed the included RCTs for risks of bias and we created a 'Summary of findings' table using GRADE. Main results We included two RCTs with a total of 121 participants. Both RCTs were of short‐term parenteral anticoagulation early after ICH: one tested heparin and the other enoxaparin. The risk of bias in the included RCTs was generally unclear or low, with the exception of blinding of participants and personnel, which was not done. The included RCTs did not report our chosen primary outcome (a composite outcome of all serious vascular events including ischaemic stroke, myocardial infarction, other major ischaemic event, ICH, major extracerebral haemorrhage, and vascular death). Parenteral anticoagulation did not cause a statistically significant difference in case fatality (RR 1.25, 95% confidence interval (CI) 0.38 to 4.07 in one RCT involving 46 participants, low‐quality evidence), ICH, or major extracerebral haemorrhage (no detected events in one RCT involving 75 participants, low‐quality evidence), growth of ICH (RR 1.64, 95% CI 0.51 to 5.29 in two RCTs involving 121 participants, low‐quality evidence), deep vein thrombosis (RR 0.99, 95% CI 0.49 to 1.96 in two RCTs involving 121 participants, low quality evidence), or major ischaemic events (RR 0.54, 95% CI 0.23 to 1.28 in two RCTs involving 121 participants, low quality evidence). Authors' conclusions There is insufficient evidence from RCTs to support or discourage the use of antithrombotic treatment after ICH. RCTs comparing starting versus avoiding antiplatelet or anticoagulant drugs after ICH appear justified and are needed in clinical practice." @default.
• W2616971700 created "2017-06-05" @default.
• W2616971700 creator A5000524196 @default.
• W2616971700 creator A5014800121 @default.
• W2616971700 creator A5019765687 @default.
• W2616971700 creator A5029929483 @default.
• W2616971700 creator A5033617127 @default.
• W2616971700 creator A5034088593 @default.
• W2616971700 creator A5065181810 @default.
• W2616971700 creator A5090391636 @default.
• W2616971700 date "2017-05-25" @default.
• W2616971700 modified "2023-10-18" @default.
• W2616971700 title "Antithrombotic treatment after stroke due to intracerebral haemorrhage" @default.
• W2616971700 cites W1498265361 @default.
• W2616971700 cites W1565336877 @default.
• W2616971700 cites W1580748765 @default.
• W2616971700 cites W1624156324 @default.
• W2616971700 cites W1816712423 @default.
• W2616971700 cites W1973567538 @default.
• W2616971700 cites W1973732466 @default.
• W2616971700 cites W1982902952 @default.
• W2616971700 cites W2026458612 @default.
• W2616971700 cites W2039982366 @default.
• W2616971700 cites W2041196331 @default.
• W2616971700 cites W2042398312 @default.
• W2616971700 cites W2043148633 @default.
• W2616971700 cites W2056326312 @default.
• W2616971700 cites W2059193904 @default.
• W2616971700 cites W2063528788 @default.
• W2616971700 cites W2069992413 @default.
• W2616971700 cites W2076774160 @default.
• W2616971700 cites W2083716289 @default.
• W2616971700 cites W2087512895 @default.
• W2616971700 cites W2105908213 @default.
• W2616971700 cites W2112742264 @default.
• W2616971700 cites W2120086574 @default.
• W2616971700 cites W2120979457 @default.
• W2616971700 cites W2127777646 @default.
• W2616971700 cites W2128178138 @default.
• W2616971700 cites W2135533213 @default.
• W2616971700 cites W2152409603 @default.
• W2616971700 cites W2154814156 @default.
• W2616971700 cites W2155070090 @default.
• W2616971700 cites W2156513409 @default.
• W2616971700 cites W2160038959 @default.
• W2616971700 cites W2162690060 @default.
• W2616971700 cites W2163570199 @default.
• W2616971700 cites W2167703030 @default.
• W2616971700 cites W2168934316 @default.
• W2616971700 cites W2314938408 @default.
• W2616971700 cites W2316495823 @default.
• W2616971700 cites W2339754032 @default.
• W2616971700 cites W2345412692 @default.
• W2616971700 cites W2463406035 @default.
• W2616971700 cites W2514797521 @default.
• W2616971700 cites W2515341923 @default.
• W2616971700 cites W2561627031 @default.
• W2616971700 cites W2616971700 @default.
• W2616971700 cites W4290749263 @default.
• W2616971700 cites W4298311999 @default.
• W2616971700 doi "https://doi.org/10.1002/14651858.cd012144.pub2" @default.
• W2616971700 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6481874" @default.
• W2616971700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28540976" @default.
• W2616971700 hasPublicationYear "2017" @default.
• W2616971700 type Work @default.
• W2616971700 sameAs 2616971700 @default.
• W2616971700 citedByCount "15" @default.
• W2616971700 countsByYear W26169717002017 @default.
• W2616971700 countsByYear W26169717002018 @default.
• W2616971700 countsByYear W26169717002019 @default.
• W2616971700 countsByYear W26169717002020 @default.
• W2616971700 countsByYear W26169717002022 @default.
• W2616971700 countsByYear W26169717002023 @default.
• W2616971700 crossrefType "journal-article" @default.
• W2616971700 hasAuthorship W2616971700A5000524196 @default.
• W2616971700 hasAuthorship W2616971700A5014800121 @default.
• W2616971700 hasAuthorship W2616971700A5019765687 @default.
• W2616971700 hasAuthorship W2616971700A5029929483 @default.
• W2616971700 hasAuthorship W2616971700A5033617127 @default.
• W2616971700 hasAuthorship W2616971700A5034088593 @default.
• W2616971700 hasAuthorship W2616971700A5065181810 @default.
• W2616971700 hasAuthorship W2616971700A5090391636 @default.
• W2616971700 hasBestOaLocation W26169717002 @default.
• W2616971700 hasConcept C126322002 @default.
• W2616971700 hasConcept C127413603 @default.
• W2616971700 hasConcept C156957248 @default.
• W2616971700 hasConcept C168563851 @default.
• W2616971700 hasConcept C17744445 @default.
• W2616971700 hasConcept C199539241 @default.
• W2616971700 hasConcept C2771230 @default.
• W2616971700 hasConcept C2776478404 @default.
• W2616971700 hasConcept C2777015399 @default.
• W2616971700 hasConcept C2777094939 @default.
• W2616971700 hasConcept C2777736543 @default.
• W2616971700 hasConcept C2779473830 @default.
• W2616971700 hasConcept C2780645631 @default.
• W2616971700 hasConcept C2909817843 @default.
• W2616971700 hasConcept C44249647 @default.
• W2616971700 hasConcept C535046627 @default.
• W2616971700 hasConcept C71924100 @default.

• next